ArticleCancers2023

Prognoses of Patients with Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy before Surgery: A Retrospective Analysis.

Shichao Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.